1 - 10 out of 17Page size: 10
  1. 2023

  2. TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors

    Alsalloum, A., Alrhmoun, S., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Lopatnikova, J., Kurilin, V., Volynets, M., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 16 Oct 2023, In: Biomedicines. 11, 10, 2805.

    Research output: Contribution to journal › Article › peer-review

  3. Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4

    Alsalloum, A., Shevchenko, J., Fisher, M., Philippova, J., Perik-Zavodskii, R., Perik-Zavodskaia, O., Alrhmoun, S., Lopatnikova, J., Vasily, K., Volynets, M., Zavjalov, E., Solovjeva, O., Akahori, Y., Shiku, H., Silkov, A. & Sennikov, S., 13 Oct 2023, In: International Journal of Molecular Sciences. 24, 20, 15134.

    Research output: Contribution to journal › Article › peer-review

  4. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., 15 Mar 2023, In: Cancers. 15, 6, 1779.

    Research output: Contribution to journal › Review article › peer-review

  5. Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma

    Anmut, V. S., Tyrinova, T. V., Batorov, E. V., Aristova, T. A., Sizikova, S. A., Ushakova, G. Y., Denisova, V. V. & Chernykh, E. R., 2023, In: Medical Immunology (Russia). 25, 5, p. 1159-1164 6 p.

    Research output: Contribution to journal › Article › peer-review

  6. Attempt to assess direct interactions between tumor burden, myeloid-derived suppressor cells and PD-1- and TIM-3-expressing T cells in multiple myeloma patients

    Batorov, E. V., Aristova, T. A., Pronkina, N. V., Denisova, V. V., Sizikova, S. A. & Ushakova, G. Y., 2023, In: Medical Immunology (Russia). 25, 5, p. 1151-1158 8 p.

    Research output: Contribution to journal › Article › peer-review

  7. Two approaches to modeling the risk of progressive atherosclerosis

    Lozhkina, N. G., Voskoboynikov, Y. E., Kopylov, V. N., Parkhomenko, O. M. & Voevoda, M. I., 2023, In: Sibirskij Zurnal Kliniceskoj i Eksperimental'noj Mediciny. 38, 2, p. 89-97 9 p.

    Research output: Contribution to journal › Article › peer-review

  8. 2022

  9. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions

    Alrhmoun, S. & Sennikov, S., 14 Dec 2022, In: Cancers. 14, 24, 6173.

    Research output: Contribution to journal › Review article › peer-review

  10. In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes

    Shevchenko, J. A., Lopatnikova, J. A., Khantakova, J. N., Silkov, A. N., Kuznetsova, M. S., Kurilin, V. V., Maksyutov, A. Z. & Sennikov, S. V., Jun 2022, In: Frontiers in Bioscience - Landmark. 27, 6, 170.

    Research output: Contribution to journal › Article › peer-review

  11. Влияние блокады рецептора IL-7 на продукцию IFN-γ и IL-4 CD4+-клетками памяти у больных вульгарным псориазом

    Kolerova, A. V., Blinova, E. A., Kozlov, V. A. & Sergeeva, I. G., 2022, In: Klinicheskaya Dermatologiya i Venerologiya. 21, 2, p. 194-200 7 p., 7.

    Research output: Contribution to journal › Article › peer-review

  12. 2021

  13. Ligand-regulated expression of TNF receptors 1 and 2 determines receptor-mediated functional responses

    Alshevskaya, A., Koneva, O., Belomestnova, I., Lopatnikova, J., Evsegneeva, I., Zhukova, J., Kireev, F., Karaulov, A. & Sennikov, S., 1 Nov 2021, In: International Archives of Allergy and Immunology. 182, 11, p. 1077-1088 12 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 24866910